Write in a clean editor, then format for Cardiovascular Intervention and Therapeutics in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Cardiovascular Intervention and Therapeutics is a peer-reviewed journal published by Springer Nature, covering Coronary Interventions and Diagnostics, Cardiac Valve Diseases and Treatments, Cardiac Imaging and Diagnostics.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. Cardiovascular Intervention and Therapeutics 12, 45–58 (2023).
Formats any DOI in Cardiovascular Intervention and Therapeutics style. No sign-up. |
| Publishes research in | Coronary Interventions and Diagnostics Cardiac Valve Diseases and Treatments Cardiac Imaging and Diagnostics Peripheral Artery Disease Management Vascular Procedures and Complications |
| ISSN | 1868-4297 |
| Citation impact (2-yr) | 2.48 |
| h-index | 39 |
| i10-index | 290 |
| Total citations | 9,849 |
| Article processing charge | $3,590 |
| Top institutions publishing here | Tokai University |
| Journal website | www.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Interventional and Therapeutics (CVIT) society proposed an…
Cardiovascular interventions have achieved a level of excellence, with many outstanding advanced techniques and results. The mission of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) is to further our understanding of cardiovascular intervention and establish its procedural safety. [1] The Japanese Percutaneous Coronary Intervention (J-PCI) registry was established and sponsored by CVIT, and…
Drug-coated balloon (DCB) technology was developed to deliver the antiproliferative drugs to the vessel wall without leaving any permanent prosthesis or durable polymers. The absence of foreign material can reduce the risk of very late stent failure, improve the ability to perform bypass-graft surgery, and reduce the need for long-term dual antiplatelet therapy, potentially reducing…
Quantitative coronary angiography (QCA) remains to play an important role in clinical trials and post-marketing surveillance related to the safety and efficacy of new PCI devices. In this document, the current standard methodology of QCA is summarized. In addition, its history, recent development and future perspectives are also reviewed.
